General introduction

From Inflammation to Cancer: Advances in Diagnosis and Therapy for Gastrointestinal and Hepatological Diseases

Volumn , Issue , 2012, Pages 3-14

  Wu, Chung Wah ^a   Yu, Jun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84971320492     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789814343602_0001     Document Type: Chapter

References (23)

1. Gillen CD, Walmsley RS, Prior P et al. (1994) Ulcerative colitis and Crohn’s disease: A comparison of the colorectal cancer risk in extensive colitis. Gut 35:1590-2.
2. Choi PM, Zelig MP. (1994) Similarity of colorectal cancer in Crohn’s disease and ulcerative colitis: Implications for carcinogenesis and prevention. Gut 35:950-4.
3. Fireman Z, Grossman A, Lilos P et al. (1989) Intestinal cancer in patients with Crohn’s disease. A population study in central Israel. Scand J Gastroenterol 24:346-50.
4. Munkholm P, Langholz E, Davidsen M, Binder V. (1993) Intestinal cancer risk and mortality in patients with Crohn’s disease. Gastroenterology 105:1716-23.
5. Persson PG, Karlen P, Bernell O et al. (1994) Crohn’s disease and cancer: A population-based cohort study. Gastroenterology 107:1675-9.
6. Urba S. (2004) Esophageal cancer: Preoperative or definitive chemoradia-tion. Ann Oncol 15(Suppl 4): 93-6.
7. Wild CP, Hardie LJ. (2003) Reflux, Barrett’s oesophagus and adenocarcinoma: Burning questions. Nat Rev Cancer 3:676-84.
8. Nehra D, Howell P, Williams CP et al. (1999) Toxic bile acids in gastro-oesophageal reflux disease: Influence of gastric acidity. Gut 44:598-602.
9. Donato F, Tagger A, Gelatti U et al. (2002) Alcohol and hepatocellular carcinoma: The effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 155:323-31.
10. Adams LA, Lymp JF, St Sauver J et al. (2005) The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 129:113-21.
11. Regimbeau JM, Colombat M, Mognol P et al. (2004) Obesity and diabetes as a risk factor for hepatocellular carcinoma. Liver Transpl 10:S69-73.
12. Teli MR, Day CP, Burt AD et al. (1995) Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 346:987-90.
13. Uemura N, Okamoto S, Yamamoto S et al. (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784-9.
14. Yamagata H, Kiyohara Y, Aoyagi K et al. (2000) Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population: The Hisayama study. Arch Intern Med 160:1962-8.
15. Huang JQ, Sridhar S, Chen Y et al. (1998) Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114:1169-79.
16. Hsu PI, Lai KH, Hsu PN et al. (2007) Helicobacter pylori infection and the risk of gastric malignancy. Am J Gastroenterol 102:725-30.
17. Leung WK, Lin SR, Ching JY et al. (2004) Factors predicting progression of gastric intestinal metaplasia: Results of a randomised trial on Helicobacter pylori eradication. Gut 53:1244-9.
18. Sung JJ, Lin SR, Ching JY et al. (2000) Atrophy and intestinal metaplasia one year after cure of H. pylori infection: A prospective, randomized study. Gastroenterology 119:7-14.
19. Wong BC, Lam SK, Wong WM et al. (2004) Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: A randomized controlled trial. JAMA 291:187-94.
20. Azuma T, Suto H, Ito Y et al. (2001) Gastric leptin and Helicobacter pylori infection. Gut 49:324-9.
21. Furuta T, Shirai N, Xiao F et al. (2002) Effect of Helicobacter pylori infection and its eradication on nutrition. Aliment Pharmacol Ther 16:799-806.
22. Hamada H, Haruma K, Mihara M et al. (2000) High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: Impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 14:729-35.
23. Balkwill F, Mantovani A. (2001) Inflammation and cancer: Back to Virchow? Lancet 357:539-45.